Precipio and cardinal health sign distribution agreement for its hemescreen® portfolio of molecular assays for cancer

New haven, conn., feb. 06, 2024 (globe newswire) -- specialty cancer diagnostics company precipio, inc. (nasdaq: prpo) announces it has entered into a distribution agreement with cardinal health for its hemescreen molecular assay products.

PRPO Ratings Summary

PRPO Quant Ranking